References
Barrie SA. Heidelberg pH capsule gastric
analysis. In Pizzorno JE, Murray MT eds. Textbook of Natural Medicine,
Volume 1. Seattle, Washington John Bastyr College Publications, 1992.
Bennett JE. Diagnosis and treatment of fungal infections. In:
Harrison’s Online. June 2004a. Available at:
http://harrisons.accessmedicine.com/. Accessed September 30, 2004.
Bennett JE. Candidiasis. In: Harrison’s Online. 2004b Sep. Available
at: http://harrisons.accessmedicine.com/. Accessed September 30, 2004.
Braunwald DE, Kasper DL, et al. Harrison’s Principles of Internal
Medicine. 15th ed. New York: McGraw-Hill Medical Publishing Division;
2001.
Buddington RK, Williams CH, et al. Dietary supplement of neosugar
alters the fecal flora and decreases activities of some reductive
enzymes in human subjects. Am J Clin Nutr. 1996 May;63(5):709–16.
CDC (Centers for Disease Control). Candidiasis. 2003 Dec. Available
at: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/candidiasis_t.htm.
Accessed May 21, 2004.
Chami F, Chami N, et al. Evaluation of carvacrol and eugenol as
prophylaxis and treatment of vaginal candidiasis in an immunosuppressed
rat model. J Antimicrob Chemother. 2004 Nov;54(5):909–14.
Chami N, Bennis S, et al. Study of anticandidal activity of
carvacrol and eugenol in vitro and in vivo. Oral Microbiol Immunol.
2005 Apr;20(2):106–11.
Edwards L. The diagnosis and treatment of infectious vaginitis. Dermatol Ther. 2004 March;17(1):102.
Eggimann P, Garbino J, et al. Epidemiology of Candida species
infections in critically ill non-immunosuppressed patients. Lancet Inf
Dis. 2003 Dec;3(12):772-85.
Elmer GW, Surawicz CM, et al. Biotherapeutic agents: A neglected
modality for the treatment and prevention of selected intestinal and
vaginal infections. JAMA. 1996 Mar 20;275(11):870–6.
Guaschino S, De Seta F, et al. Efficacy of maintenance therapy with
topical boric acid in comparison with oral itraconazole in the
treatment of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol.
2001 Mar;184(4):598-602.
Hammer KA, Carson CF, et al. In vitro susceptibility of Malassezia
furfur to the essential oil of Melaleuca alternifolia. J Med Vet Mycol.
1997 Sep-Oct;35(5):375–7.
Han Y, Lee JH. Berberine synergy with amphotericin B against
disseminated candidiasis in mice. Biol Pharm Bull. 2005 Mar;28(3):541–4.
Hilton E, Isenberg HD, et al. Ingestion of yogurt containing
Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann
Intern Med. 1992 Mar 1;116(5):353–7.
Howard MD, Gordon DT, et al. Dietary fructooligosaccharide,
xylooligosaccharide and gum arabic have variable effects on cecal and
colonic microbiota and epithelial cell proliferation in mice and rats.
J Nutr. 1995 Oct;125(10):2604–9.
Hronek M, Vachtlova D, et al. [Antifungal effect in selected natural
compounds and probiotics and their possible use in prophylaxis of
vulvovaginitis]. Ceska Gynekol. 2005 Sep;70(5):395-9. Review.
Hudson T. Yeast vulvo vaginitis: Women’s Health Update. Townsend
Letter for Doctors and Patients. 2003 Jan. Available at:
http://www.findarticles.com/p/articles/mi_m0ISW/is_2003_Jan/ai_95676552.
Accessed March 13, 2005.
Iwalokun BA, Ogunledun A, et al. In vitro antimicrobial properties
of aqueous garlic extract against multidrug-resistant bacteria and
Candida species from Nigeria. J Med Food. 2004 fall;7(3):327–33.
Jovanovic R, Congema E, et al. Antifungal agents vs. boric acid for
treating chronic mycotic vulvovaginitis. J Reprod Med. 1991
Aug;36(8):593–7.
Kuipers ME, de Vries HG, et al. Synergistic fungistatic effects of
lactoferrin in combination with antifungal drugs against clinical
Candida isolates. Antimicrob Agents Chemother. 1999 Nov;43(11):2635–41.
Lemar KM, Passa O, et al. Allyl alcohol and garlic (Allium sativum)
extract produce oxidative stress in Candida albicans. Microbiology.
2005 Oct;151(Pt 10):3257–65.
Lupetti A, Danesi R, et al. Antimicrobial peptides: Therapeutic
potential for the treatment of Candida infections. Expert Opin Investig
Drugs. 2002 Feb;11(2):309–18. Review.
McGinnis MR, Molina TC, et al. Evaluation of the Biolog MicroStation
system for yeast identification. J Med Vet Mycol. 1996
Sep-Oct;34(5):349–52.
Mitchell H. Vaginal discharge: Causes, diagnosis, and treatment. BMJ. 2004 May 29;328(7451):1206–8.
Nola I, Kostovic K, et al. Candida infections today: How big is the problem? Am J Obstet Gynecol. 2003 Nov;189(5):1297–300.
Orsi N. The antimicrobial activity of lactoferrin: Current status and perspectives. Biometals. 2004 Jun;17(3):189–96. Review.
Oyarzabal OA, Conner DE. In vitro fructooligosaccharide utilization
and inhibition of Salmonella spp. by selected bacteria. Poult Sci. 1995
Sep;74(9):1418–25.
PDR. Physician’s Desk Reference. New York: Simon & Schuster; 2004.
Percival M. Intestinal health. Clin Nutr Insights. 1997;5(5):1–6.
Rushton RT et al. The future of medicine: the effect of tea tree oil
extract on the growth of fungi. Lower Extremity. 1997;4(2):113–6.
Samaranayake YH, Samaranayake LP, et al. Antifungal effects of
lysozyme and lactoferrin against genetically similar, sequential
Candida albicans isolates from a human immunodeficiency virus-infected
southern Chinese cohort. J Clin Microbiol. 2001 Sep;39(9):3296–302.
Shalev E, Battino S, et al. Ingestion of yogurt containing
Lactobacillus acidophilus compared with pasteurized yogurt as
prophylaxis for recurrent candidal vaginitis and bacterial vaginosis.
Arch Fam Med. 1996 Nov-Dec; 5(10):593–6.
Sheppard D, Lampiris HW. Antifungal drugs. In: Katzung B, ed. Basic
and Clinical Pharmacology, 9th ed. New York: McGraw-Hill/Lange Medical
Books; 2004.
Slobodnikova L, Kost’alova D, et al. Antimicrobial activity of
Mahonia aquifolium crude extract and its major isolated alkaloids.
Phytother Res. 2004 Aug;18(8):674–6.
Sobel JD, Chaim W, et al. Treatment of vaginitis caused by Candida
glabrata: use of topical boric acid and flucytosine. Am J Obstet
Gynecol. 2003 Nov;189(5):1297-300.
Tampieri MP, Galuppi R, et al. The inhibition of Candida albicans by
selected essential oils and their major components. Mycopathologia.
2005 Apr;159(3):339–45.
van der Kraan MI, Nazmi K, et al. Lactoferrampin, an antimicrobial
peptide of bovine lactoferrin, exerts its candidacidal activity by a
cluster of positively charged residues at the C-terminus in combination
with a helix-facilitating N-terminal part. Biol Chem. 2005
Feb;386(2):137–42.
Viejo-Diaz M, Andres MT, et al. Different anti-Candida activities of
two human lactoferrin-derived peptides, Lfpep and kaliocin-1.
Antimicrob Agents Chemother. 2005 Jul;49(7):2583–8.
Print
PDF
Email
View Health Concern
